The National Advisory Committee on Immunization is expected to change its stance on the AstraZeneca COVID-19 vaccine to now recommend its use for Canadians over the age of 65, a senior government source tells CTV News.
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe